Maria Martinez‐García

First-in-Human, Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of RO5126766, a First-in-Class Dual MEK/RAF Inhibitor in Patients with Solid Tumors

Maria Martinez‐García, Udai Banerji, Joan Albanell et al. · Clinical Cancer Research · 2012 · 151 citations

A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples

Anna Esteve‐Codina, Oriol Arpí, Maria Martinez‐García et al. · PLoS ONE · 2017 · 145 citations · Full text

Engineering, Pathology, Transcriptomics Technology +24

Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial

Sònia Pernas, Miguel Martín, Peter A. Kaufman et al. · The Lancet Oncology · 2018 · 133 citations

Breast Oncology, Oncology, Medicine +8

Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study

Giuseppe Curigliano, P. Gómez Pardo, Funda Meric‐Bernstam et al. · The Breast · 2016 · 132 citations · Full text

NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival

Aura Muntasell, Federico Rojo, Sònia Servitja et al. · Clinical Cancer Research · 2019 · 130 citations